Terms: = Ovarian cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Diagnosis
917 results:
1. Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or ovarian cancer.
Torres-Esquius S; Llop-Guevara A; Gutiérrez-Enríquez S; Romey M; Teulé À; Llort G; Herrero A; Sánchez-Henarejos P; Vallmajó A; González-Santiago S; Chirivella I; Cano JM; Graña B; Simonetti S; Díaz de Corcuera I; Ramon Y Cajal T; Sanz J; Serrano S; Otero A; Churruca C; Sánchez-Heras AB; Servitja S; Guillén-Ponce C; Brunet J; Denkert C; Serra V; Balmaña J
JAMA Netw Open; 2024 Apr; 7(4):e247811. PubMed ID: 38648056
[TBL] [Abstract] [Full Text] [Related]
2. Bayesian and deep-learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers.
Abrego L; Zaikin A; Marino IP; Krivonosov MI; Jacobs I; Menon U; Gentry-Maharaj A; Blyuss O
Cancer Med; 2024 Apr; 13(7):e7163. PubMed ID: 38597129
[TBL] [Abstract] [Full Text] [Related]
3. Survival of European adolescents and young adults diagnosed with cancer in 2010-2014.
Trama A; Botta L; Stiller C; Visser O; Cañete-Nieto A; Spycher B; Bielska-Lasota M; Katalinic A; Vener C; Innos K; Marcos-Gragera R; Paapsi K; Guevara M; Demuru E; Mousavi SM; Blum M; Eberle A; Ferrari A; Bernasconi A; Lasalvia P;
Eur J Cancer; 2024 May; 202():113558. PubMed ID: 38489859
[TBL] [Abstract] [Full Text] [Related]
4. A clinicopathological study about the epidemiology of granulosa cell tumors in Lebanon.
Yaacoub S; Hajj L; Khairallah A
BMC Cancer; 2024 Mar; 24(1):309. PubMed ID: 38448917
[TBL] [Abstract] [Full Text] [Related]
5. cancer Risks Associated With
Fortuno C; Feng BJ; Carroll C; Innella G; Kohlmann W; Lázaro C; Brunet J; Feliubadaló L; Iglesias S; Menéndez M; Teulé A; Ballinger ML; Thomas DM; Campbell A; Field M; Harris M; Kirk J; Pachter N; Poplawski N; Susman R; Tucker K; Wallis M; Williams R; Cops E; Goldgar D; ; James PA; Spurdle AB
JCO Precis Oncol; 2024 Feb; 8():e2300453. PubMed ID: 38412388
[TBL] [Abstract] [Full Text] [Related]
6. Smoking, Drinking, and Dietary Risk Factors for Head and Neck cancer in Prostate, Lung, Colorectal, and ovarian cancer Screening Trial Participants.
Lander DP; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):249-256. PubMed ID: 38329760
[TBL] [Abstract] [Full Text] [Related]
7. Modern Subtype Classification and Outlier Detection Using the Attention Embedder to Transform ovarian cancer diagnosis.
Nobel SMN; Swapno SMMR; Hossain MA; Safran M; Alfarhood S; Kabir MM; Mridha MF
Tomography; 2024 Jan; 10(1):105-132. PubMed ID: 38250956
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.
Landolfo C; Ceusters J; Valentin L; Froyman W; Van Gorp T; Heremans R; Baert T; Wouters R; Vankerckhoven A; Van Rompuy AS; Billen J; Moro F; Mascilini F; Neumann A; Van Holsbeke C; Chiappa V; Bourne T; Fischerova D; Testa A; Coosemans A; Timmerman D; Van Calster B
Br J Cancer; 2024 Apr; 130(6):934-940. PubMed ID: 38243011
[TBL] [Abstract] [Full Text] [Related]
9. Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
Wang Y; Dackus GMHE; Rosenberg EH; Cornelissen S; de Boo LW; Broeks A; Brugman W; Chan TWS; van Diest PJ; Hauptmann M; Ter Hoeve ND; Isaeva OI; de Jong VMT; Jóźwiak K; Kluin RJC; Kok M; Koop E; Nederlof PM; Opdam M; Schouten PC; Siesling S; van Steenis C; Voogd AC; Vreuls W; Salgado RF; Linn SC; Schmidt MK
BMC Med; 2024 Jan; 22(1):9. PubMed ID: 38191387
[TBL] [Abstract] [Full Text] [Related]
10. Breast Health Awareness: Understanding Health-Seeking Behavior in Western Kenya.
Bhatia MB; Kisilu N; Kiptoo S; Limenik I; Adaniya E; Kibiwot S; Wabende LN; Jepkirui S; Awuor DA; Morgan J; Loehrer PJ; Hunter-Squires JL; Busakhala N
Ann Surg Oncol; 2024 Feb; 31(2):1190-1199. PubMed ID: 38044347
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of the diagnostic efficiency between the O-RADS US risk stratification system and doctors' subjective judgment.
Zhou S; Guo Y; Wen L; Liu J; Fu Y; Xu F; Liu M; Zhao B
BMC Med Imaging; 2023 Nov; 23(1):190. PubMed ID: 37986051
[TBL] [Abstract] [Full Text] [Related]
12. A retrospective study of Pipelle endometrial biopsy for ovarian, fallopian tube, and peritoneal cancers.
Tamura R; Kitani Y; Takahashi K; Yamaguchi M; Nishikawa N; Kawasaki T; Kikuchi A
J Obstet Gynaecol; 2023 Dec; 43(2):2283162. PubMed ID: 37983014
[TBL] [Abstract] [Full Text] [Related]
13. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
[TBL] [Abstract] [Full Text] [Related]
14. ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of ovarian cancer Screening (UKCTOCS).
Dilley J; Gentry-Maharaj A; Ryan A; Burnell M; Manchanda R; Kalsi J; Singh N; Woolas R; Sharma A; Williamson K; Mould T; Fallowfield L; Campbell S; Skates SJ; McGuire A; Parmar M; Jacobs I; Menon U
Gynecol Oncol; 2023 Dec; 179():123-130. PubMed ID: 37980767
[TBL] [Abstract] [Full Text] [Related]
15. Development and validation of age-specific risk prediction models for primary ovarian insufficiency in long-term survivors of childhood cancer: a report from the Childhood cancer Survivor Study and St Jude Lifetime Cohort.
Im C; Lu Z; Mostoufi-Moab S; Delaney A; Yu L; Baedke JL; Han Y; Sapkota Y; Yasui Y; Chow EJ; Howell RM; Bhatia S; Hudson MM; Ness KK; Armstrong GT; Nathan PC; Yuan Y
Lancet Oncol; 2023 Dec; 24(12):1434-1442. PubMed ID: 37972608
[TBL] [Abstract] [Full Text] [Related]
16. Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast cancer.
Kabirian R; Franzoi MA; Havas J; Coutant C; Tredan O; Levy C; Cottu P; Dhaini Mérimèche A; Guillermet S; Ferrero JM; Giacchetti S; Petit T; Dalenc F; Rouanet P; Everhard S; Martin AL; Pistilli B; Lambertini M; Vaz-Luis I; Di Meglio A
JAMA Netw Open; 2023 Nov; 6(11):e2343910. PubMed ID: 37971739
[TBL] [Abstract] [Full Text] [Related]
17. Top-Down Proteomics of Human Saliva, Analyzed with Logistic Regression and Machine Learning Methods, Reveal Molecular Signatures of ovarian cancer.
Scebba F; Salvadori S; Cateni S; Mantellini P; Carozzi F; Bisanzi S; Sani C; Robotti M; Barravecchia I; Martella F; Colla V; Angeloni D
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958700
[TBL] [Abstract] [Full Text] [Related]
18. Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study.
Tian C; Wen SB; Zhao CY; Yan XN; Du JX
BMC Womens Health; 2023 Nov; 23(1):585. PubMed ID: 37940895
[TBL] [Abstract] [Full Text] [Related]
19. Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study.
Ruan X; Huang D; Zhan Y; Huang J; Huang J; Ng AT; Tsu JH; Na R
Elife; 2023 Nov; 12():. PubMed ID: 37917154
[TBL] [Abstract] [Full Text] [Related]
20. Association of guideline-concordant care with survival, health care utilization, and costs among older women with advanced epithelial ovarian cancer.
Kamat S; Brown BR; Hume A; Vyas A
Am J Manag Care; 2023 Oct; 29(10):e292-e298. PubMed ID: 37870550
[TBL] [Abstract] [Full Text] [Related]
[Next]
